We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

15 hedge funds and large institutions have $3.59M invested in Achieve Life Sciences in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

102% more capital invested

Capital invested by funds: $1.78M → $3.59M (+$1.81M)

36% more funds holding

Funds holding: 11 → 15 (+4)

0.27% less ownership

Funds ownership: 1.09% → 0.83% (-0.27%)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Searle & Co
Connecticut
+$148K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$148K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$71.5K
4
WVP
Worth Venture Partners
New Jersey
+$68.7K
5
Renaissance Technologies
Renaissance Technologies
New York
+$68.3K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$542K
2
SCM
Sio Capital Management
New York
-$355K
3
UBS Group
UBS Group
Switzerland
-$1.98K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$1.36M -$355K -8,795 -29%
Renaissance Technologies
2
Renaissance Technologies
New York
$923K +$68.3K +1,690 +13%
WVP
3
Worth Venture Partners
New Jersey
$399K +$68.7K +1,701 +38%
Vanguard Group
4
Vanguard Group
Pennsylvania
$352K +$148K +3,665 +206%
SC
5
Searle & Co
Connecticut
$237K +$148K +3,675 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$119K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$114K +$71.5K +1,769 New
Citadel Advisors
8
Citadel Advisors
Florida
$54K +$33.6K +831 New
BlackRock
9
BlackRock
New York
$27K – – –
Bank of America
10
Bank of America
North Carolina
$1K +$525 +13 New
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$1K +$768 +19 New
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$262 – – –
AC
13
Armistice Capital
New York
– -$542K -22,400 Closed
UBS Group
14
UBS Group
Switzerland
– -$1.98K -49 Closed
Morgan Stanley
15
Morgan Stanley
New York
– +$283 +7 +700%
Deutsche Bank
16
Deutsche Bank
Germany
– +$404 +10 New

ACHV Hedge Fund Activity: Q1 2019 in Review

15 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2019, worth a combined $3.59M — up 102% from $1.78M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ACHV positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Searle & Co, opening a new position worth an estimated $148K. The largest seller was Armistice Capital, exiting entirely with an estimated $542K sold.

  • 15 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2019, up from 11 in Q4 2018.
  • Funds reported $3.59M of Achieve Life Sciences stock for Q1 2019, up 102% quarter-over-quarter.
  • 6 funds opened new Achieve Life Sciences positions in Q1 2019 and 2 closed out, a net change of +4 holders.
  • The largest Achieve Life Sciences buyer in Q1 2019 was Searle & Co, an estimated $148K added.
  • The largest Achieve Life Sciences seller in Q1 2019 was Armistice Capital, an estimated $542K sold.

Based on aggregated 13F filings for Q1 2019.